eradication therapy should be different for dyspeptic patients than for ulcer patients
Clicks: 130
ID: 165963
2003
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
130 views
8 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #149 of 250 articles by views in indian journal of pharmacology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 250 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Physicians should try to achieve an optimal cure rate with their initial
Helicobacter pylori eradication therapy. Most physicians use the
same treatment in all their patients. H pylori infection in patients
with peptic ulcer disease (PUD) is more likely to be cured than that
in patients with functional dyspepsia (FD). Differences in cure rates
of 5% to 15% are usually reported, which is considered to be clinically
relevant. A plausible biological explanation for this finding suggests
that different strains (virulent [cagA+, vacA type s1] compared
with nonvirulent strains [cagA–, vacA type s2]) in PUD and FD
induce different changes in the gastric mucosa, and this facilitates or
impairs antimicrobial efficacy. Physicians should be aware that most
published treatment studies have included only PUD patients. This
means that in clinical practice cure rates obtained in patients with
FD or perhaps uninvestigated dyspepsia are usually lower than those
reported in the literature. This has implications for the choice of
treatment. Physicians should consider prolonging the duration of initial
Helicobacter eradication therapy from seven to 10 to 14 days in
patients without ulcers.
| Reference Key |
boer2003canadianeradication
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Wink A de Boer |
| Journal | indian journal of pharmacology |
| Year | 2003 |
| DOI |
10.1155/2003/136716
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.